SYN NAT PRODUCTS ENTPR LLC has a total of 32 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SYN-NAT PRODUCTS ENTPR LLC, BIONUMERIK PHARMACEUTICALS INC and TMRC CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 6 | |
#3 | Australia | 5 | |
#4 | Brazil | 4 | |
#5 | China | 4 | |
#6 | Republic of Korea | 4 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Liu Xiaozhong | 25 |
#2 | Xiaozhong Liu | 6 |
#3 | Ye Zhao | 2 |
#4 | Liang Zhang | 2 |
#5 | Jirui Xi | 2 |
#6 | Zhao Ye | 1 |
#7 | Zhang Liang | 1 |
#8 | Xi Jirui | 1 |
Publication | Filing date | Title |
---|---|---|
CN107847521A | Pharmaceutical co-crystals composition and application thereof | |
CN108697093A | Composition and application thereof containing carboplatin | |
KR20180018800A | Pharmaceutical compositions of the carboplatin based co-crystals and uses thereof | |
BR112017024727A2 | cocrystal, pharmaceutical composition, method of treatment of a disease in an individual and production process of a cocrystal | |
EP3285758A1 | Co-crystal composition and its pharmaceutical use |